USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
26 Jul 2023 | 03:00 PM GMT

From Algorithms to Assets: Monetising Real-World Patient Data with AI

Anchored by:

Lisa Suennen
Managing Partner, AHA Ventures
LISA SUENNEN

Participants:

Lisa Suennen Managing Partner, AHA VenturesLisa Suennen
Lisa Suennen
Managing Partner, AHA VenturesLisa Suennen
Aahuti Rai NED & Venture PartnerFour Points Health
Aahuti Rai
NED & Venture PartnerFour Points Health
AnnaLisa Daniele Director, Connected CareBaxter Healthcare
AnnaLisa Daniele
Director, Connected CareBaxter Healthcare
Gregoire Guillet Chief Business and Value OfficerWeHealth Digital Medicine
Gregoire Guillet
Chief Business and Value OfficerWeHealth Digital Medicine
Harvey Castro Chief Clinical Operating OfficerViTel Health
Harvey Castro
Chief Clinical Operating OfficerViTel Health
Jeff Weness VP Growth and StrategyRefinedScience
Jeff Weness
VP Growth and StrategyRefinedScience
Jeremy Forman VP, Research & Development AI, DataPfizer
Jeremy Forman
VP, Research & Development AI, DataPfizer
Josh Marquart Chief Strategy OfficerMentorMate
Josh Marquart
Chief Strategy OfficerMentorMate
Patrick Leyseele Founder3.life
Patrick Leyseele
Founder3.life
Ralph Morales III Managing DirectorShokunin Ventures
Ralph Morales III
Managing DirectorShokunin Ventures
Sheena Dempsey Chief Solutions Officer Indivi
Sheena Dempsey
Chief Solutions Officer Indivi

About this Meeting

Artificial Intelligence (AI) is disrupting traditional business models by extracting deeper insights from diverse data sets.

AI is an invaluable tool in the monetisation of real-world patient data, enabling the enhancement of Real-World Evidence (RWE) generation, discovery of new targets, enhancement of connected devices, optimisation of trial design etc. Through AI, we can map the diagnosis and treatment paths of millions of patients in real-time, identify opportunities to improve outcomes, and transform patient data into predictive tools for better healthcare management.

Join us in this roundtable discussion as we unravel the most effective strategies to harness AI to transform real-world patient data into actionable insights and revenue generating activities. We'll explore:

  • The Potential of AI as a Data Monetisation Tool. How can AI enhance value generation from patient data, and what are the untapped possibilities of AI in monetizing real-world data?
  • Data Monetisation Models. What are the best business models for monetising patient data (i.e. selling anonymized data, AI-driven analytics services, leveraging AI for increased efficiency)?
  • Navigating the Ethical, Legal, and Privacy Landscape. There are ethical dilemmas when monetising patient data - how can we ensure patient data protection and  ethical AI use?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.